Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension
about
Noninvasive intraocular pressure monitoring: current insightsStrategies for improving early detection of glaucoma: the combined structure-function indexIs 24-hour intraocular pressure monitoring necessary in glaucoma?Oral microbiome link to neurodegeneration in glaucomaPredicting progression of glaucoma from rates of frequency doubling technology perimetry changeComparison of HRT-3 glaucoma probability score and subjective stereophotograph assessment for prediction of progression in glaucoma.Diagnostic tools for glaucoma detection and management.The African Descent and Glaucoma Evaluation Study (ADAGES): design and baseline data.Relationship between pattern electroretinogram, standard automated perimetry, and optic nerve structural assessmentsA new method for determining physician decision thresholds using empiric, uncertain recommendations.Determinants of agreement between the confocal scanning laser tomograph and standardized assessment of glaucomatous progression.Predicting the onset of glaucoma: the confocal scanning laser ophthalmoscopy ancillary study to theOcular Hypertension Treatment Study.Using CorvisST tonometry to assess glaucoma progression.Development of a risk score for geographic atrophy in complications of the age-related macular degeneration prevention trial.Prediction of functional loss in glaucoma from progressive optic disc damageIncorporating mortality risk into estimates of 5-year glaucoma riskLong-term intraocular pressure fluctuations and risk of conversion from ocular hypertension to glaucoma.Developing the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study.Glaucoma: genes, phenotypes, and new directions for therapy.Effect of dorzolamide/timolol combination on the visual field in glaucoma.Effect of 3 years of treatment with a dorzolamide/timolol (1%/0.5%) combination on intraocular pressure.The effect of changes in intraocular pressure on the risk of primary open-angle glaucoma in patients with ocular hypertension: an application of latent class analysisThe Heidelberg retina tomograph ancillary study to the European glaucoma prevention study: study design and baseline factors.Distribution of central corneal thickness and its association with ocular parameters in a large central European cohort: the Gutenberg health study.Evaluation of progressive neuroretinal rim loss as a surrogate end point for development of visual field loss in glaucoma.The accuracy and clinical application of predictive models for primary open-angle glaucoma in ocular hypertensive individuals.Clinical characteristics and current treatment of glaucoma.Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.A Joint Model for Prognostic Effect of Biomarker Variability on Outcomes: long-term intraocular pressure (IOP) fluctuation on the risk of developing primary open-angle glaucoma (POAG)Expression of glucose transporters in the prelaminar region of the optic-nerve head of the pig as determined by immunolabeling and tissue cultureStereo Photo Measured ONH Shape Predicts Development of POAG in Subjects With Ocular HypertensionEffect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group.Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.Stratification of phaco-trabectome surgery results using a glaucoma severity index in a retrospective analysis.Risk of Ocular Hypertension in Adults with Noninfectious Uveitis.A validated risk calculator to assess risk and rate of visual field progression in treated glaucoma patients.Predicting Development of Glaucomatous Visual Field Conversion Using Baseline Fourier-Domain Optical Coherence Tomography.Spectral analysis of intraocular pressure pulse wave in ocular hypertensive and primary open angle glaucoma patientsPredicting development of proliferative diabetic retinopathyPredicting progression in glaucoma suspects with longitudinal estimates of retinal ganglion cell counts.
P2860
Q26800246-4CE7F96F-3A8B-4C68-948F-58C3B5B2A56FQ26997010-F877BCEB-D6FA-405B-8E2C-F9EC12629522Q27014089-819706A3-9CC7-4D9B-BEC8-0EB1BD6C5871Q27316016-055D0FA1-0C4B-46BC-9209-D07C315FE5D7Q31144659-9F5D0E52-B749-40BE-BA4D-AF5E0B91BA65Q33330813-58179E31-346B-498E-945C-927899667871Q33387777-BAC9783F-A219-4573-BEF4-CFA1193EF49AQ33502968-C77F12E7-F317-444B-863F-12A2224ACFDBQ33510330-75A35589-0D41-4483-9F58-35B8E456A979Q33551018-6566707F-B30A-4BAA-814D-19622743342DQ33608338-8746F616-29E6-4A8E-87F7-602B96E57AE0Q33633604-8D671271-9D30-40DB-9096-5BB43E9E59BAQ33637599-BA703EB6-37BB-4F30-B5A8-D254A04B5BDCQ33676775-BDF2D46F-1C01-45F4-8644-8B39CBBA5F8AQ33687236-A81792B9-5282-451D-936D-B2710EE3F742Q33694660-1C478FBD-6C1C-4106-B052-D79365A355C6Q33764018-AFD9D551-CBA5-4411-B2A8-573B138C10EAQ33878922-A002DE70-BFEE-491B-9DA7-FB8D293BC27BQ34090204-22675AF5-B70A-4AC3-B1BB-CB203CFB5591Q34134877-3D3018A0-41CE-4FED-9D08-7401DB72EA79Q34182293-C4C4FD09-29AF-4A4C-B9E3-4682A3ABE2B2Q34433542-D5CB324A-6D77-4814-8E7C-1EC09E7C909BQ34741660-B7A3E381-4C34-40EB-A90E-33A7D4EED3F0Q34923866-01B45EC0-F569-4D87-8741-1A24DB36FDBAQ34944081-2030BE94-C2CF-4DCB-A97D-B65C8877FDEFQ35052597-A33D6472-4B4B-44AD-A683-D8E372D9CDE2Q35180374-23EC70F9-6F13-499F-81F5-851B028B79B7Q35250502-4F7D07AE-53C2-42DF-9E5F-C9244A898538Q35612531-E25244F2-54D8-4480-AA28-A79E1FC98F59Q35647692-07774C7C-51C6-4F07-865D-5078F12AE120Q35870341-40F6C1CE-636D-4DE4-927E-D2F0C4D3DD0AQ35929958-F72F2DA5-457F-4D97-8A3B-13D0ECC82A29Q36016475-34FCC5FA-D48E-4EB6-B566-C70D87AAAAF7Q36317555-F72898D5-F19F-430A-85A7-C559A88858BCQ36354205-04B47D1B-F759-47C3-84FE-2A8340438C81Q36390585-4FDDA2FA-0F12-4824-8252-071B1F8F153EQ36627014-A335CD46-1EAD-4919-9C3F-579E0FE8440EQ36851244-F9A4E940-EFE6-4B62-9D85-F35F829F31F5Q36868163-F927EB04-29B6-4BC7-8807-5FC7C43795FCQ36943814-ACDCEE32-CDE7-47D4-B9BB-C4798A1031D8
P2860
Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Validated prediction model for ...... duals with ocular hypertension
@ast
Validated prediction model for ...... duals with ocular hypertension
@en
type
label
Validated prediction model for ...... duals with ocular hypertension
@ast
Validated prediction model for ...... duals with ocular hypertension
@en
prefLabel
Validated prediction model for ...... duals with ocular hypertension
@ast
Validated prediction model for ...... duals with ocular hypertension
@en
P2093
P2860
P1433
P1476
Validated prediction model for ...... duals with ocular hypertension
@en
P2093
Davide Poli
European Glaucoma Prevention Study Group
Ingrid Adamsons
Irene Floriani
J Philip Miller
Julia A Beiser
Mae O Gordon
Michael A Kass
Ocular Hypertension Treatment Study Group
P2860
P356
10.1016/J.OPHTHA.2006.08.031
P577
2006-11-07T00:00:00Z